Sometimes the simplest things can be the hardest to do correctly, and nowhere else could it be more devastating than when a glucagon kit is not used properly. In this week’s Disaster Averted, see what could happen when a medical professional gets ahold of a simple-to-use device and overthinks it. …
Read More »Letter from the Editor, #739
Each year when I talk to educators about the AADE meeting, I often find out that they can’t go because it is not their year. For most of them this means that their employer is only sending one or two educators a year and it is not their turn. If …
Read More »Editor’s Note, DCMS #198
The mixing up of mixed insulins can cause problems for some of our patients especially if they are trying to achieve the best control possible. This week our Disaster Averted looks at what can happen when a patient is given the wrong analog. Our Clinical Text looks at the cost …
Read More »Editor’s Note, Special GLP-1 Edition, July 2014
We know that patients lose a great deal of weight after bariatric surgery. Often times some of the weight comes off fast in the beginning and then slowly after that. More importantly these patients have a quick resolution of hyperglycemia and improvement in fasting, post prandial and hemoglobin A1c readings. …
Read More »Letter from the Editor, #738: Afrezza
After a long battle and comments from many doubters the FDA has approved the inhaled insulin, Afrezza. As soon as the approval came the nay-sayers were quick to remind us of what a failure Exubera had been and there was no way that this new inhaled insulin stood a chance. …
Read More »Editor’s Note, DCMS #197
For the past year we have been providing you with a monthly white paper on SGLT-2 inhibitors and for the past 7 weeks we have been discussing the emerging role that the kidney plays in glucose homeostasis. This week our Homerun Slides look at how the kidney has a profound effect …
Read More »Editor’s Note, SGLT2-Inhibitor Special Edition, July 2014
When the first SGLT-2 inhibitor came to the market we went to doctors all over the country and asked them their opinions on this new class of drugs. The overwhelming response was "wait and see." Now a year later we asked them again to tell us how they feel about …
Read More »Letter from the Editor #737
There was an article in Diabetologia 2014 stating that, "Whey protein may represent a novel approach for enhancing glucose-lowering strategies in type 2 diabetes." I wonder why we need these studies as common sense says any time you add protein to a meal digestion will slow and glucose levels won’t …
Read More »Editor’s Note, DCMS #196
First it was the Quintessential Quintet, then the Setaceous Sextet, and Septicidal Septet was next in our discussion of causes of hyperglycemia — now, this week in our Homerun Slides, we look at the Ominous Octet and how that affects hyperglycemia and glucose control. Dr. Rudy Bilous, Professor of Clinical …
Read More »Letter from the Editor, #736: High Blood Sugar Mystery
Can you all help me with a couple of things? I know from experience that many of our readers are very physically active and health conscious. In talking with some of my colleagues, many select lower carb regimens to follow. This often leads us to take on long bouts of …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.